Navigation Links
Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat

WATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2007 - Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the results of a new study indicating that HIV resistant to Protease Inhibitors (PI) may have reduced potential for the development of resistance to the HIV maturation inhibitor bevirimat in laboratory assays. The study, carried out by scientists in Dr. Eric Freed's group at the HIV Drug Resistance Program at the National Cancer Institute, Frederick, MD, in collaboration with Panacos, was presented at the Cold Spring Harbor Laboratory's (CSHL) Retrovirus Conference held May 22-27, 2007 in Cold Spring Harbor, NY.

While resistance to bevirimat has not yet been reported in clinical studies, bevirimat-resistant HIV can be generated in the laboratory, as is the case with other HIV drugs. In previous studies where HIV was grown for several weeks in cell culture in the presence of bevirimat at suboptimal concentrations, mutations conferring resistance to bevirimat were found exclusively at or near bevirimat's target, the capsid-SP1 cleavage site in the HIV Gag protein. Cleavage of capsid from SP1, the final step in viral maturation, is mediated by the viral protease enzyme. Bevirimat inhibits this cleavage step by interacting with the capsid-SP1 junction in Gag, suggesting that pre-existing PI resistance mutations may have an impact on the development of bevirimat resistance.

In the new study, wild-type HIV, as well as HIV bearing major mutations conferring PI resistance, were grown in cell culture in the presence of bevirimat at suboptimal concentrations. Bevirimat resistance developed after several weeks in both wild-type and PI-resistant HIV, but took more than twice as long to develop in the PI-resistant virus. The bevirimat resistance mutation that appeared in PI-resistant virus was located at th
'"/>




Page: 1 2 3

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
Post Your Comments:
(Date:9/22/2014)... N.J. , Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... fourth quarter and fiscal 2014 ended July 31, 2014 on ... conference call to discuss the results at 11:00 AM ET. ... , Chairman; Andrew A. Krakauer , President and CEO; ... Craig A. Sheldon , Senior Vice President, CFO and ...
(Date:9/22/2014)... Pa. , Sept. 22, 2014  Olympus, ... innovative solutions for medical and surgical procedures, among ... a deal with Munich -based ... Kick ® Navigation. This agreement applies to ... for cross-disciplinary U.S. sales and all distribution outside ...
(Date:9/22/2014)... , Sept. 22, 2014  For many people ... often means facing the prospect of large, painful ... imagined, regular activities are also impacted, such as ... severity of the problem, some patients even delay ... can even lead to permanent damage for some ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2
... Pharmacy Technician Certification Board (PTCB) launches the ... pharmacy profession on recommended changes to the PTCB ... pharmacy technician exams and additional requirements for PTCB ... practical experience, criminal background checks, and completion of ...
... 1, 2012 A consistent theme within healthcare ... innovation and disease treatment is progression.  An example ... in healthcare IT, which is expected to become ... healthcare industry.  Companies must maintain a vantage point ...
Cached Medicine Technology:PTCB Calls For Profession-wide Feedback on Proposed Changes to Certification Program 2Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 2Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 3
(Date:9/22/2014)... The Advocator Group, LLC— The Advocator ... with the RxCut® pharmacy savings program, which will make ... The company looks forward to offering prescription savings cards ... in which they deliver on the goal to guide ... For All® Inc., the RxCut® pharmacy savings ...
(Date:9/22/2014)... 2014 Caliper, an internationally recognized talent ... honored once again with the When Work Works Award ... has allowed Caliper to increase business and employee success. ... to meet both work and family commitments effectively. As ... at an all-time high. , “At Caliper, our ...
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 ... Annual Meeting, the nonprofit Seafood Nutrition Partnership (SNP) ... called Eating Heart Healthy: A Cardiovascular Risk Reduction ... to help women understand and mitigate their risk ... SNP’s Commitment to Action, a plan for addressing ...
(Date:9/22/2014)... The Disease Theory of Addiction ... as a disease embraces the notion that it ... person being chronically ill genetically and even including ... , Narconon Arrowhead, an effective rehabilitation center ... holistic approach to rehabilitating the addict or alcoholic ...
(Date:9/22/2014)... 2014 Today has been designated World ... a form of blood cancer that affects approximately 5,000 ... mutation affecting chromosomes 22 and 9. So that date ... the worldwide community unites to raise awareness about the ... at the forefront of the current revolution in cancer ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC Announces Partnership with Pharmacy Savings Program RxCut® 2Health News:The Advocator Group, LLC Announces Partnership with Pharmacy Savings Program RxCut® 3Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 2Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 4Health News:Narconon Arrowhead Offers Information on Disease Theory of Addiction in New Release of Booklet 2Health News:Narconon Arrowhead Offers Information on Disease Theory of Addiction in New Release of Booklet 3Health News:Marking World CML Day on September 22nd 2Health News:Marking World CML Day on September 22nd 3
... Ganz, an assistant Professor of Society, Human Development, and Health ... of autism for US society //and has found that the ... span. Ganz has published his research in the new book ... In his study, titled, “The Costs of Autism,” Ganz says ...
... open a second cancer hospital, this time in the southern ... up in Karachi by January next year, the Daily Times ... had set up the Shaukat Khanum Memorial Cancer Hospital and ... state-of-the-art cancer centre was Khan's tribute to his mother Shaukat ...
... Organization (IMO) has expressed his interest to contest in the ... the party’s former Justice Minister held the seat. ... North constituency and is positive about the success in the ... of May. ,‘The people of North Dublin were ...
... Indonesia's resort island of Bali, health officials have culled more ... The birds had been smuggled to Bali from the adjacent ... ,More than 24 bird flu related deaths have ... response to the above situation, import of poultry and livestock ...
... Caracas found that Lactobacillus casei (L casei), when fermented ... increased the nutritional value. Beans are a cheap and ... ,Marisela Granito led the Venezuelan team to ... compromising on the nutritional value. The research appears in ...
... by the Liverpool University suggests that men are more aware ... their most fertile. The researchers felt that men// become more ... girlfriends are at their most fertile. ,The Evolution ... men suggested those with ovulating partners were vary wary of ...
Cached Medicine News:Health News:The Price Of Autism 2Health News:Jealousy In Men Peaks When Partners Are Most Fertile 2
The Secur-Fit cups incorporate enhancements derived from years of clinical, radiographic, and implant retrieval observations....
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
Implex cemented hip stem....
M2 cemented hip stem....
Medicine Products: